
Japanese business still needs to do more to reach gender equality
Japanese business still needs to do more to reach gender equality
Japan's Takeda Pharma has announced the appointment of Julie Kim as its first woman CEO, marking a significant milestone for the country's drug industry. Christophe Weber, who was previously the first non-Japanese CEO, oversaw a reorientation that included the $62 billion acquisition of British rival Shire in 2019. Despite underperformance in share price over five years, Takeda's US-listed shares have dropped almost 30 percent in the same period. The government has set a target for firms to raise the proportion of female executives to 30% or more by 2030. Shareholders will vote on Kim's appointment in June 2026. This is testament to progress toward gender equality in Japanese business.